Company: AIP
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0001667011-25-000022
Chunk: 2

Company: Arteris, Inc.
Filing Date: 2025-05-13
Form: 10-Q
Item: Part I, Item 1
Chunk 2
---
,127)$(9,469)

See accompanying notes to unaudited condensed consolidated financial statements.

5

Arteris, Inc.

Condensed Consolidated Statements of Stockholders' (Deficit) Equity

(In thousands, except share data)

(Unaudited)

Stockholders’ DeficitAdditionalAccumulated OtherCommon StockPaid-InComprehensiveAccumulatedSharesAmountCapitalIncomeDeficitTotalBALANCE—December 31, 202440,724,936 $40 $135,522 $135 $(136,885)$(1,188)Issuance of common stock upon exercise of stock options145,959 — 148 — — 148 Issuance of common stock for settlement of Restricted Stock Units (RSUs)532,399 1 (1)— — — Stock-based compensation expense— — 4,346 — — 4,346 Unrealized losses on available-for-sale securities, net of tax— — — (6)— (6)Net loss— — — — (8,121)(8,121)BALANCE—March 31, 202541,403,294 $41 $140,015 $129 $(145,006)$(4,821)

Stockholders’ EquityAdditionalAccumulated OtherCommon StockPaid-InComprehensiveAccumulatedSharesAmountCapitalIncomeDeficitTotalBALANCE—December 31, 202337,518,583 $37 $118,193 $120 $(103,247)$15,103 Issuance of common stock upon exercise of stock options246,692 — 255 — — 255 Issuance of common stock for settlement of RSUs526,150 1 (1)— — — Stock-based compensation expense— — 3,657 — — 3,657 Unrealized losses on available-for-sale securities, net of tax— — — (66)— (66)Net loss— — — — (9,403)(9,403)BALANCE—March 31, 202438,291,425 $38 $122,104 $54 $(112,650)$9,546 

See accompanying notes to unaudited condensed consolidated financial statements.

6

Arteris, Inc.

Condensed Consolidated Statements of Cash Flows